Dukebox Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing

Secondary Activities: Medical Equipment and Supplies Manufacturing | Chemical and Allied Products Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Department Stores | Electronic Shopping and Mail-Order Houses | Research and Development in Biotechnology (except Nanobiotechnology) | All Other Miscellaneous Ambulatory Health Care Services

Full name: Dukebox Sp. z o.o.

Profile Updated: May 03, 2024

Dukebox Sp. z o.o. is an enterprise in Poland, with the main office in Warsaw. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. It was established on February 19, 2016. It currently has a total number of 1 (2016) employees. A negative growth of 1.03% was recorded in its total assets.

Headquarters
Ul. Okopowa 33
Warsaw; Mazowieckie; Postal Code: 01-059

Contact Details: Purchase the Dukebox Sp. z o.o. report to view the information.

Basic Information

Total Employees:

Purchase the Dukebox Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Dukebox Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Dukebox Sp. z o.o. report to view the information.

Incorporation Date:

February 19, 2016

Key Executives

Purchase this report to view the information.

President

Ownership Details

Purchase this report to view the information.

55%

Purchase this report to view the information.

45%

Company Performance

Financial values in the chart are available after Dukebox Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Operating Profit/Loss (EBIT)

95.76%▲

EBITDA

95.76%▲

Net Profit/Loss for the Period

95.76%▲

Total Assets

-1.03%▼

Total Equity

-0.85%▼

Return on Equity (ROE)

-19.31%▼

Similar companies